Twenty-four seven
7074
Alpico Holdings
297A
Branding Technology
7067
Estore
4304
Axel Mark
3624
JP Stock MarketDetailed Quotes
4896 K Pharma
- 614
- +14+2.33%
20min DelayMarket Closed Dec 27 15:30 JST
7.13BMarket Cap26.61P/E (Static)
628High601Low7.50KVolume601Open600Pre Close4.59MTurnover101652wk High0.50%Turnover Ratio11.60MShares55052wk Low-65.788EPS TTM927.69MFloat Cap1016Historical High26.61P/E (Static)1.51MShs Float531Historical Low23.07EPS LYR4.50%Amplitude--Dividend TTM2.66P/B100Lot Size--Div YieldTTM
K Pharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | 225.74%456.31M | -84.95%-362.91M | -196.22M |
| Net profit before non-cash adjustment | 177.09%301.08M | -70.45%-390.53M | ---229.12M |
| Total adjustment of non-cash items | 76.72%65.03M | 123.98%36.8M | --16.43M |
| -Depreciation and amortization | ---- | ---- | --6.8M |
| -Reversal of impairment losses recognized in profit and loss | 37.75%43.11M | 280.42%31.29M | --8.23M |
| -Other non-cash items | 298.13%21.93M | 293.08%5.51M | --1.4M |
| Changes in working capital | 1,082.26%90.2M | -155.77%-9.18M | --16.47M |
| -Change in inventory | -91.05%-598K | -1,638.89%-313K | ---18K |
| -Change in payables | -76.57%1.75M | 6,375.63%7.47M | ---119K |
| -Changes in other current assets | 55.87%-7.88M | -320.93%-17.86M | --8.08M |
| -Changes in other current liabilities | 6,268.59%96.93M | -82.13%1.52M | --8.52M |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | -4K | ||
| Interest received (cash flow from operating activities) | 128.57%16K | 600.00%7K | 1K |
| Tax refund paid | -227.76%-1.9M | -504.17%-580K | -96K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 |
| Operating cash flow | 225.02%454.43M | -85.15%-363.48M | ---196.32M |
| Investing cash flow | |||
| Net PPE purchase and sale | 67.28%-9.8M | ---29.96M | --0 |
| Net changes in other investments | 53.36%-1.3M | -1,011.60%-2.78M | ---250K |
| Investing cash flow | 66.10%-11.1M | -12,994.80%-32.74M | ---250K |
| Financing cash flow | |||
| Net issuance payments of debt | ---- | ---- | ---30M |
| Net common stock issuance | -3.11%1.5B | 287.84%1.54B | --398.2M |
| Net other fund-raising expenses | -11,111.11%-10.09M | ---90K | ---- |
| Financing cash flow | -3.76%1.49B | 319.41%1.54B | --368.2M |
| Net cash flow | |||
| Beginning cash position | 608.14%1.34B | 1,000.71%188.78M | --17.15M |
| Current changes in cash | 68.07%1.93B | 568.92%1.15B | --171.63M |
| Cash adjustments other than cash changes | ---- | ---1K | ---- |
| End cash Position | 144.34%3.27B | 608.14%1.34B | --188.78M |
| Free cash flow | 213.01%444.62M | -100.41%-393.44M | ---196.32M |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |